AC Immune SA Share Price & Technical Analysis
ACIU · $2.83 (-0.70%)
Healthcare / Biotechnology
$2.83
-0.70%
AC Immune SA, a clinical stage biopharmaceutical company, discovers, designs, and develops medicines, and therapeutic and diagnostic products for the prevention and treatment of neurodegenerative diseases associated with protein misfolding. The company's SupraAntigen and Morphomer platforms are designed to generate biologics and small molecules, which selectively interact with misfolded proteins t…
Price chart
Seasonality
May has 2 positive and 2 negative years (last 5 years shown)
-7% return in May, 35% avg return in past 3 year May month.
-9% return in 2026, 36% avg return in past 3 years.
Swipe sideways to see all months →
| Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | Yr | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 26 | 0% | -9% | 0% | 7% | -7% | – | – | – | – | – | – | – | -9% |
| 25 | 4% | -7% | -24% | -11% | 0% | 18% | 10% | -5% | 38% | 17% | -9% | 3% | 34% |
| 24 | -36% | 9% | -19% | -17% | 88% | -18% | 5% | -22% | 19% | -26% | 17% | -21% | -21% |
| 23 | 19% | -8% | 0% | -17% | 16% | 20% | 3% | 7% | -15% | 7% | 10% | 52% | 93% |
| 22 | -14% | -7% | 0% | -12% | -11% | 16% | -3% | -14% | 3% | -16% | -11% | -23% | -91% |
Monthly return % by calendar month · historical pattern, not a forecast
Bearish · Downtrend · Neutral
AC Immune SA, a clinical stage biopharmaceutical company, discovers, designs, and develops medicines, and therapeutic and diagnostic products for the prevention and treatment of neurodegenerative diseases associated with protein misfolding. The company's SupraAntigen and Morphomer platforms are designed to generate biologics and small molecules, which selectively interact with misfolded proteins that are common in a range of neurodegenerative diseases. It develops Crenezumab, a humanized, conformation specific monoclonal antibody used to slow Alzheimer's disease (AD) progression; and Semorinemab, an investigational monoclonal anti-Tau antibody that targets the N-terminal portion of the Tau protein and is designed to bind to Tau and slow its spread between neurons for the treatment of AD. The company is also developing ACI-24.060 for the treatment of down syndrome related AD; ACI-7104.056 to treat Parkinson's disease; and ACI-35.030, designs to stimulate a patient's immune system to produce antibodies against pathological phosphorylated Tau. In addition, it develops diagnostic programs consisting of PI-2620, a Tau diagnostic for AD, as well as non-AD Tauopathies; and ACI-12589 and ACI-15916, a-sync PET tracer that supports the differential diagnosis of multiple system atrophy from other neurodegenerative diseases. Further, the company is researching and developing Morphomer Tau aggregation inhibitors to evaluate candidates in AD; Morphomer a-syn to compete with small molecule inhibitors of a-syn aggregation; and NeuroOrphan Tauopathies. Additionally, it generates discovery and preclinical stage molecules targeting range of neurodegenerative diseases, which include diagnostics targeting TDP-43, alpha-synuclein, and NLRP3. The company has license agreements and collaborations with Genentech, Inc.; Janssen Pharmaceuticals, Inc.; Life Molecular Imaging SA; and Eli Lilly and Company. AC Immune SA was incorporated in 2003 and is headquartered in Lausanne, Switzerland.
Full AI Q&A, portfolio tracking, and live alerts in the app.
Key metrics
Market cap
$282.42M
P/E ratio
—
52W high
$4.00
52W low
$1.60
Volume
78,142
Beta
1.63
Related stocks in Healthcare
Merck & Co Inc Cedear (5…
₹32,900
Abbott Laboratories Cede…
₹30,500
Eli Lilly And Company Ce…
₹25,540
Unitedhealth Group Inc C…
₹17,200
₹6,600
Frequently asked questions
- What is AC Immune SA share price today?
- AC Immune SA (ACIU) last traded around $2.83 on StockPro. Prices refresh every few minutes during market hours.
- What technical signals does ACIU have?
- StockPro monitors breakouts, volume spikes, EMA reversals, and momentum for ACIU. Download the app for real-time alerts.
- How can I analyze AC Immune SA stock?
- Use the price chart, seasonality heatmap, key metrics, and AI insight on this page. For portfolio tracking and push alerts, download StockPro on Android or iOS.